These rankings are based on data from May 2025
MindRank utilizes proprietary AI platforms for small-molecule drug discovery, focusing on hard-to-drug targets. Its innovations led to MDR-001, a GLP-1 RA drug, obtaining US IND approval for obesity and diabetes treatment.
API Availability
- No
Pricing
unknown
Industries
health & sports
Insights
What kind of AI expert are you?
Understanding the 4 layers of the AI expert iceberg
Norway’s AI builders: Key Insights from the AI Report Norway 2025
Norway’s AI sector is growing fast, but who is actually building the technology that will shape the future? The newly released AI Report Norway 2025 offers the first data-driven overview of the companies developing new AI-powered products and solutions in the country.